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Abstract
The delivery of effector proteins by Salmonella across the host cell membrane requires a subset of effectors secreted by the
type III secretion system (TTSS) known as translocators. SipC and SipB are translocator proteins that are inserted into host
membranes and presumably form a channel that translocates type III effectors into the host cell. The molecular events of
how these translocators insert into the host cell membrane remain unknown. We have previously shown that the SipC C-
terminal amino acid region (321–409) is required for the translocation of effectors into host cells. In this study, we
demonstrate that the ability to form SipC-SipB complex is essential for their insertion into the host membrane. The SipB-
interacting domain of SipC is near its C-terminal amino acid region (340–409). In the absence of SipB, SipC was not detected
in the membrane fraction. Furthermore, SipC mutants that no longer interact with SipB are defective in inserting into the
host cell membrane. We propose a mechanism whereby SipC binds SipB through its C-terminal region to facilitate
membrane-insertion and subsequent translocon formation in the host cell membrane.
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Introduction
Many gram negative bacterial pathogens utilize type three
secretion systems (TTSS) to translocate virulence factors into host
cells to exploit host-cell functions for their own benefit. Salmonella
enterica serovar Typhimurium (S. typhimurium), use the TTSS to
cause gastroenteritis and typhoid fever in both humans and
animals by delivering type III effectors into host cells [1,2,3,4,5].
The transport of bacterial effector proteins across the host cell
membrane is facilitated by a subset of Salmonella effector proteins
that are known as translocators: SipB, SipC, and SipD. These
translocators presumably form a channel in the host cell
membrane that enables the passage of bacterial effectors across
the host cell membrane [6,7,8,9]. The functional equivalents of
Salmonella SipB, SipC and SipD in other pathogenic bacteria
include; IpaB, IpaC and IpaD in Shigella spp.; YopB, YopD and
LcrV in Yersinia spp.; PopB, PopD and PcrV for Pseudomonas spp.;
EspA, EspD, and EspB in Enteropathogenic Escherichia coli (EPEC)
[10,11,12].
SipB and SipC associate with artificial membranes and localize
to the host cell membrane through their putative hydrophobic
regions [13,14]. All three translocators, SipB, SipC and SipD, are
required to form functional pores during Salmonella infection of
erythrocytes [15]. SipC, SipB, and SipD were further shown to be
required for the intimate association of Salmonella with mammalian
cells [16]. The intimate attachment of Salmonella with host cells is
believed to trigger the TTSS while the insertion of SipC and SipB
into membranes and pore formation are conceived to be
important for protein translocation into host cells. The oligomer-
ization of SipC is believed to be essential for the translocon pore
formation [17]. In addition, it has been shown that SipC forms an
extracellular complex with SipB during secretion [14,18]. It was
speculated that the SipB-SipC complex is important for the
channel formation and the translocation of effectors into the host
cell. However, how SipB and SipC insert into the host cell
membrane and how the channels are formed remains unknown.
In this study, we present evidence that the complex formation
between SipC and SipB is essential for the insertion of both
proteins into the host cell membrane during Salmonella invasion.
We propose a mechanism whereby SipC binds SipB through its C-
terminal region to facilitate subsequent translocon formation.
Results
Pore forming activities of SipC C-terminal mutant strains
SipC is approximately 43 KDa and contains a predicted 80
amino acids central hydrophobic region flanked by the N-terminal
120 amino acid residues and 209 amino acids toward the C-
terminus (Fig. 1A and [14]). The C-terminal region has been
shown to mediate the actin modulation and the effector
translocation functions of SipC using the in-frame deletion/
insertion replacement approach [14,18,19,20]. The central
hydrophobic region is predicted to play a role in membrane
anchoring. The potential activities of the SipC N-terminal region
may include effector secretion and/or translocation.
Type III secretion systems deliver effector proteins across the
host cell membrane presumably by forming channels in the
plasma membrane. This is supported by the observation that
Shigella and Salmonella are hemolytic in a type III secretion-
dependent manner [10,15]. We have previously shown that the
translocation activity of SipC is mediated by the C-terminus of
SipC [19]. To understand whether the translocation defect
observed were due to the pore forming activity, we examined
the hemolytic activity of SipC C-terminal mutant #1–#10 strains
[15,19]. The SipC mutants #1 to #6 maintained wild-type levels
of hemolysis while SipC mutant #7 to #10 had drastically
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reduced hemolysis activities (Fig. 1B), suggesting that this regions
might be important for the pore forming activity and effector
translocation.
Previous studies have demonstrated that the hemolytic lysis of
RBC by Shigella could be prevented by addition of osmotic
protectants. Osmotic protectants that are too large to pass through
the bacteria-induced pore can counterbalance the intracellular
osmotic pressure, leading to reduced hemolysis [10]. Molecules
larger than PEG2000 (2.8 nm) can often prevent the hemolytic
lysis induced by Salmonella [15]. To further determine whether the
hemolytic activities of the sipC C-terminal mutant strains were due
to pore formation, we performed osmoprotection experiments as
previously described [15]. This assay allowed us to distinguish pore
formation from other types of membrane damage that may lead to
osmotic shock and hemolysis [10]. Various carbohydrates, i.e.
raffinose (diameter 1.2–1.4 nm), PEG1000 (1.8 nm), PEG1500
(2.2–2.3 nm), PEG2000 (2.8 nm) and PEG3000 (3.2 nm) were
added to the RBC before infection (30 mM). Consistent with the
previous report [15], molecules larger than PEG1500 conferred
significant protection against lysis induced by wild-type Salmonella
as well as mutant #1–#6 strains (Fig. 1C). Osmoprotection was
not observed when the null sipC strain or Mt#7–#10 strains were
used, suggesting that the residual hemolysis was due to a pore
larger than PEG3000 or from destabilization of the membrane by
unknown mechanism similar to that reported previously [10].
Together, this data confirms the importance of the SipC C-
terminus in the translocation activity, which requires the formation
of pores approximately 2 nm or less.
The N-terminal of SipC possesses domains for secretion
and chaperone binding
To fully characterize the functional region responsible for
effector translocation, we made 6 in-frame deletion/insertion
replacement mutations in the Salmonella chromosome throughout
the N-terminal region of SipC (residues 1–120) (Fig. 2A) [19]. To
understand whether the SipC N-terminal mutant strains have
altered pore forming activities, we examined the hemolytic activity
of SipC N-terminal mutant N1–N6 strains. The SipC mutants N2,
N3, N4, and N6 maintained wild-type levels of hemolysis while
SipC mutant N1 and N5 strains had drastically reduced hemolysis
activities (Fig. 2B).
Type III effectors often harbor the secretion and translocation
signals at their N-terminal regions. Thus, the reduced hemolytic
activities of SipC mutant N1 and N5 strains may have altered
secretion and/or translocation of type III effectors. To test
whether the SipC N-terminal mutations affected the type III
effector secretion, we examined the expression and secretion of
SipC, SipB, SipD, and SipA proteins in these N-terminal mutant
strains. Similar levels of expression and secretion were observed in
sipC-N2, sipC-N3, sipC-N4 and sipC-N6 mutant strains (Fig. 2C). In
contrast, the sipC-N1 mutant strain failed to secret SipC-N1 even
though its expression was comparable to that of the wild-type
strain. This observation suggests that the N-terminal 20 residues
are important for SipC secretion [21]. Interestingly, SipC-N5 was
detected at drastically lower amounts in both the lysate and
secreted fractions. Further experiments showed that the wild-type
SipC-N and its derivatives were able to bind SicA, the chaperone
for SipC [22], except SipC-N5 (Fig. 2D). Together, these data
(Fig. 1–2) suggest that the N-terminal region (residues 1–120)
possess domains for secretion and chaperone binding and most
likely does not contain functional regions directly involved in
effector translocation, which resides at the C-terminus of SipC.
Figure 1. Pore forming activities of SipC C-terminal mutant
strains. (A) Schematic diagram of the SipC protein showing the
deletion/insertion sites in SipC. (B) Sheep Red Blood cells were infected
with various Salmonella strains and the relative hemolysis activity was
measured at OD 595 nm. The hemolysis experiments were repeated
three times with the standard errors shown. Statistical analysis of
hemolysis was performed by Student’s t test with a p value of ,0.05
being considered significant (*). When compared to the wild-type strain,
the p values of sipC, #1, #2, #3, #4, #5, #6, #7, #8, #9, and #10
mutant strains are 0.0001(***), 0.5545, 0.5598, 0.9839, 0.2650, 0.9825,
0.9793, 0.0041(**), 0.0047(**), 0.0003(***), 0.0006(***) respectively. (C)
The osmoprotection experiments were carried out in BHI media using
the hemolysis assay described in materials and methods with BHI media
alone or containing 30 mM Raffinose, PEG1000, PEG1500, PEG2000,
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The C-terminal region (340–409) of SipC is required for
SipB-SipC complex formation
Previous studies have reported that SipC forms an extracellular
complex with SipB upon secretion [14] and recombinant SipC
and SipB proteins bind to each other in vitro [17]. We have
previously shown that the SipC C-terminal region (321–409) is
required for translocation of effectors with mutant Mt#7, Mt#8,
Mt#9, and Mt#10 deficient in translocation (Fig. 1A and [19]).
We hypothesized that the loss of the translocation activities of the
SipC C-terminal mutants could be partly due to their inability to
bind to SipB. We therefore examined the ability of SipC C-
terminal mutants to form complexes with SipB by co-immuno-
precipitation using Salmonella culture supernatants. Consistent with
a previous report [14], SipC forms a complex with SipB in culture
Figure 2. Pore forming activities of SipC N-terminal mutant strains. (A) Schematic diagram of the SipC N-terminus showing the deletion/
insertion sites in SipC. (B) Sheep Red Blood cells were infected with various Salmonella strains and the relative hemolysis activity was measured at OD
595 nm. The hemolysis experiments were repeated three times with the standard errors shown. Statistical analysis of hemolysis was performed by
Student’s t test with a p value of ,0.05 being considered significant (*). When compared to the wild-type strain, the p values of sipB, sipC, sipD, invA,
sipC-N1, N2, N3, N4, N5, N6 mutant strains and the un-infected are 0.0005(***), 0.0026(**), 0.0002(***), 0.0003(***), 0.0009(***), 0.4872, 0.7540, 0.4709,
0.0124(*), 0.2500, 0.0001(***) respectively. The expression (C) and secretion (D) of SipC, SipB, SipD, SipA, and DnaK in Salmonella strains including the
wild-type, sipB, sipC, sipD, invA, sipC-N1-N6. Bacterial strains were grown under SPI-1 inducing conditions and equal amounts of bacterial lysates or
culture supernatants were analyzed by Western blotting using rabbit polyclonal anti-SipB, anti-SipC, anti-SipD, anti-SipA, monoclonal anti-M45 and
anti-DnaK antibodies. (D) SipC-N5 is defective in binding to SicA. The interactions of SipC-N, SipC-N1-N6 with SicA were analyzed by pull-down assay
using purified GST-SicA or GST as negative control. The presence of GST-SicA and His-SipC after pull down was determined by Western blotting with
polyclonal anti-GST and monoclonal anti-His antibodies.
doi:10.1371/journal.pone.0060499.g002
SipB-SipC Complex Formation
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supernatant of wild type Salmonella (Fig. 3). SipC also forms a
complex with SipB in the absence of SipD (Fig. 3) even though
SipD is required for the translocation activity. Our SipC
translocation deficient mutants Mt#8, Mt#9, and Mt#10 failed
to form the complex with SipB while wild type SipC and the
translocation competent Mt#4 strain were still capable of binding
to SipB (Fig. 3). Null sipC and sipB mutant strains were used as
negative controls. Interestingly, SipC translocation and pore
formation deficient mutant Mt#7 was still capable of forming a
complex with SipB. Although it cannot be ruled out that the
translocation activities of SipC and SipB are independent of their
binding abilities, our data indicate that SipC and SipB interaction
is important for their membrane localization and pore formation.
To ensure that the SipC mutations did not significantly alter the
conformation of the protein and therefore their binding activities,
limited proteolysis [23] was carried out for the wild-type SipC as
well as the SipC derivatives #7, #8, #9, and #10 mutants. All
the SipC mutant proteins produced similar proteolytic banding
patterns as that of the wild-type SipC (Fig. S1), suggesting that the
folding of these mutated SipC proteins was not significantly
impaired.
SipC mutants that no longer interact with SipB are also
defective in translocon assembly in the host cell
membrane
The insertion of SipB and SipC into the host plasma
membranes is believed to be a prerequisite for the formation of
a channel or a pore that enables the passage of effector proteins
from the bacteria into the host cell. Indirect evidence using sipB,
sipC, and sipD null mutant strains have shown that SipB and SipC
are not targeted to the host membranes in the absence of any one
of these translocators [13]. The molecular events and how the
SipB and SipC membrane insertion process occurs remain
unknown. For example, it is not known if SipB and SipC complex
formation is required for the membrane insertion during infection.
The availability of SipC translocation mutants gave us the
opportunity to investigate this further.
To evaluate the association of SipC and SipB with host cell
membrane during Salmonella invasion, we performed cell fraction-
ation assays using HeLa cells infected with the wild-type Salmonella
or sipC mutant derivatives (Fig. 4). As expected, we were able to
demonstrate the presence of both SipB and SipC in the membrane
fractions of host cells infected with the wild-type Salmonella. In
contrast, SipB and SipC were not detected in the membrane
fractions of cells infected with the sipB or the sipC null mutant
strains (Fig. 4). The amount of SipB and SipC in the membrane
fractions of cells infected with Mt#8, Mt#9, Mt#10, or the sipD
mutant strains were almost undetectable. Interestingly, SipB and
SipC were detected in the membrane fractions of cells infected
with Mt#7 strain at a level similar to that of the wild-type strain
(Fig. 4). This was intriguing because mutant Mt#7 is defective in
translocating effectors, but remains capable of forming a complex
with SipB (Fig. 3). SipB and SipC were also detected in the
membrane fractions of cells infected with Mt#4 mutant strain,
which is translocation competent. Caveolin-1 was used as a control
for membrane fraction while Hsp90 was used as a cytosolic
marker. SipA, a type III secreted protein that is also present on the
Salmonella surface, was used as an internal negative control to test
whether Salmonella membrane-associated proteins could have
contaminated the membrane fraction. No SipA was detected
(Fig. 4B), indicating that there are no detectable amounts of
residual Salmonella surface proteins in the host cell membrane
fractions. This data strongly suggest that the complex formation of
SipC and SipB is required for the proper host cell membrane
localization of both SipC and SipB during Salmonella infection. The
formation of functional pores requires the insertion of both SipC
and SipB in the host membrane. SipC mutants #8, 9 and 10 are
defective in hemolysis (Fig. 1), in forming complexes with SipB
(Fig. 3), and incapable of proper insertion/localization into host
membrane during infection (Fig. 4). However, the translocation
deficient mutant #7 still binds to SipB and properly inserts into
the host cell membrane. These data therefore supports the notion
that the proper insertion of SipB and SipC into the host
membrane requires the complex formation of SipB and SipC.
Wild type SipB and SipC proteins possess hydrophobic trans-
membrane regions and are capable of associating with membranes
[14,17]. We decided to examine the abilities of the wild type SipC
protein and its mutant derivatives to localize to the host cell
membrane when ectopically expressed in cultured cells. Wild-type
SipC protein and its mutants SipC-#4, #7, #8, #9, and #10 are
all capable of associating with the host cell membranes (Fig. S2).
This result suggests that the mutated proteins still capable of
localizing to the plasma membrane when expressed in the
mammalian cells.
SipC forms a complex with SipB in Salmonella infected
cells
The translocation-deficient mutant #7 was impaired in pore
formation and yet it remained capable of forming a complex with
SipB and of associating with host cell membranes. To determine if
SipB and SipC proteins translocated during infection were able to
form a complex, we carried the coimmunoprecipitation assay
using Salmonella infected cells. As shown in Fig. 5, SipB and SipC
are found in a complex when infected with the wild-type Salmonella
or the mutated SipC Mt#7 strain. This result illustrated that the
membrane extracted SipB and SipC proteins from infected
cultured cells still interact, suggesting that they may form a
complex during infection for their membrane insertion/localiza-
tion in host cells.
The multimerization and self-association abilities of translocator
proteins have been predicted to play an important role during the
translocation process [24]. To determine whether the SipC
mutated proteins were still capable of self-association, clarified
bacterial culture supernatants were cross-linked with the zero-
length cross-linker EDC. Wild-type SipC protein and all its
derivatives were still able to oligomerize as dimers, trimers, and
high order oligomers in bacterial culture supernatants (data not
shown). We also examined the oligomerization of SipC in HeLa
cells infected with wild-type Salmonella or the Mt#7 mutant strain.
Figure 3. The C-terminal region (340–409) of SipC is required
for SipB-SipC complex formation. Bacterial culture supernatants
from various Salmonella strains were immunoprecipitated with
antibodies to SipB and were probed by Western blotting using anti-
SipB and anti-SipC antibodies.
doi:10.1371/journal.pone.0060499.g003
SipB-SipC Complex Formation
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We found that SipC Mt#7 can still form oligomers as high
molecular weight species (data not shown).
Discussion
The delivery of Salmonella type III effector proteins across the
host cell membrane requires the formation of the translocon by
SipB, SipC, and SipD. This poses great challenges since the
translocator proteins are synthesized in the bacterial cytosol and
have to be secreted across the bacterial membranes and
subsequently be inserted into the host cell membranes. SipB and
SipC contain hydrophobic regions and are inserted into the host
cell membrane presumably to form a channel or pore [6,7,8,9].
SipD possesses no hydrophobic regions and is not inserted into
host cell membranes, but is also required for the formation of
functional pores. How SipB and SipC insert into the host cell
membrane is not known. We have previously reported that the
SipC C-terminal region (321–409) is required for translocation of
effectors [19]. We created a series of translocation-deficient
mutants (Mt#7 to Mt#10) that are valuable in studying the roles
of SipC in forming the translocon. We hypothesized that the loss
in the translocation activities of these SipC mutants could be
attributed to the loss in binding to SipB or in inserting into the host
cell membrane. Thus, one key question was whether SipB and
SipC complex formation is required for their insertion into the
host cell membrane.
Shigella IpaB, the functional equivalent of Salmonella SipB, has
been shown to associate with host membranes in the absence of
IpaC [10]. This is not the case for SipB, which is not found in the
host cell membranes in the absence of SipC [13]. Both SipC and
SipB associate with artificial membranes in vitro, but do not form
functional pores [17,25]. Our SipC mutant, Mt#7, which lacks
amino acids 321–340, maintained its ability to bind to SipB and
was inserted into host membranes of epithelial cells. This was in
contrast to SipC mutants that lack amino acids 340–409, which
did not interact with SipB and were not associated with host cell
membranes. This data is consistent with the notion that SipB and
SipC form a complex before being inserted into the host cell
membrane. We showed that the SipC mutants that lack amino
acid residues 321–409 fail to form functional pores in erythrocytes
using the contact hemolysis assay as an indirect indication of type
III secretion system induced pore formation. Interestingly, the
SipC mutant that lacks amino acids 321–340 (Mt#7) and is
defective in translocon pore formation was still capable of
associating with isolated RBC membranes. These findings were
in line with results in tissue cultured cells that showed that SipC
Mt#7 was still capable of associating host membranes. Although
SipD is known to be required for forming a functional pore, we
were not successful in determining any direct interactions between
SipD and SipC. Therefore we cannot rule out the possibility that
Figure 4. SipC mutants that no longer interact with SipB are
also defective in translocon assembly in the host cell
membrane. (A) HeLa cells were infected with the wild-type Salmonella
strains or its mutant derivatives as indicated. Infected cells were
fractionated and the membrane fraction (upper panel) or the cytosolic
fraction (lower panel) were resolved by SDS-PAGE and analyzed by
Western blotting with antibodies against SipB, SipC, Caveolin-1
(membrane), and Hsp90 (cytoplasmic). (B) HeLa cells were infected
with the wild-type Salmonella strains or its mutant derivatives as
indicated. The membrane and cytosolic fractions were similarly
processed and probed with antibodies against SipA, SipB and SipC.
doi:10.1371/journal.pone.0060499.g004
Figure 5. SipC forms a complex with SipB in infected cell
lysates. HeLa cells were infected with wild type Salmonella and SipC
mutant (Mt#7) strains. Infected HeLa cells were fractionated and
membrane associated proteins were immunoprecipitated with SipB
antibody. Immunoprecipitated samples were analyzed by SDS-PAGE
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SipC Mt#7 has lost its inherent interacting activity with SipD,
which ultimately allows SipC, SipB and SipD to form functional
pores.
Previous studies have indicated that oligomeric complexes
formed by the translocator proteins contribute to pore formation
in Pseudomonas [24]. We examined the abilities of SipC and its
derivatives to self-associate in bacterial culture supernatants
(secreted proteins). Our data did not show any significant
impairment in the oligomerization of the wild type SipC protein
and its derivatives (data not shown). In addition, the wild type
SipC protein and the SipC Mt#7 protein, capable of plasma-
membrane association and interaction with SipB, were able to self-
associate in the plasma-membrane of infected host cells (data not
shown). This data suggest that the loss of translocation activity by
the SipC mutants was not due to the failure of SipC to self-
assemble. This data is plausible because both the C-terminal
[14,18,19] and the N-terminal (unpublished data) truncations of
SipC can self-associate. Furthermore, both domains contain the
predicted coiled-coil domains that could facilitate such interactions
[26,27].
In summary, our results indicate that the SipC and SipB
complex formation is essential for forming a functional translocon,
possibly by inserting into host membranes as a complex during
Salmonella infection. We propose a mechanism whereby SipC binds
SipB through its C-terminal region to be in a membrane-insertion
competent state to facilitate subsequent translocon formation. Our
study does not completely preclude the possibility of sequential
insertion of SipB and SipC into the host cell membrane. Future
studies are required to gain a better understanding of how the
translocon is formed during Salmonella infection.
Materials and Methods
Bacterial Strains and mammalian cell lines
Wild-type S. typhimurium strain SL1344 (SB300), its sipC (SB220),
sipB (SB169), and sipD (SB221) null mutants have been previously
described [6,28]. In-frame chromosomal gene replacements in sipC
were carried out as described before [29] by an allelic-exchange
suicide vector pSB890. Chromosomal mutants N1-6 were
constructed using the in-frame deletion/insertion replacement
strategy similar to the Mt#7, Mt#8, Mt#9, and Mt#10 mutant
construction as described previously [19]. Briefly, in-frame
deletion/insertion replacement mutations in SipC (residues 1–
120) with the M45-tag epitope were constructed using the
polymerase chain reaction (PCR) and standard molecular biology
techniques with a two-step cloning protocol [30]. Chromosomal
gene replacements in SipC were carried out as described before by
an allelic-exchange suicide vector pSB890 [29,31]. The mamma-
lian cell lines HeLa (CCL-2), HEK293T, and NIH3T3 were
purchased from the ATCC cell biology stock center (Manassas,
VA). HeLa and HEK293T cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine
serum.
Coimmunoprecipitation and Pull-down assays
Salmonella strains were grown under SPI-I inducing conditions as
described previously [32]. Briefly, bacteria were grown overnight
at 37uC in 0.3 M LB medium, diluted 1:20 into fresh medium, and
grown for another 3 hrs at a rotation speed of 200 rpm to obtain
an OD600 of 0.8 to 0.9. Secreted proteins were recovered by three
cycles of centrifugation at 50,0006 g for 30 min each time and
pre-cleared with TrueBlot anti-Rabbit Ig IP Beads (eBioscience).
The supernatants were then incubated with rabbit polyclonal anti-
SipB antibody for 2 hrs at 4uC. TrueBlot anti-Rabbit Ig IP Beads
were subsequently added and the samples were incubated for an
additional hour at 4uC. The beads were washed four times in lysis
buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA,
1% Triton X-100). The immune-complex was separated by SDS-
PAGE and the proteins were detected by Western blot using the
TrueBlot protocol as per manufacturer’s instructions (eBioscience).
Before the pull-down assay, His- or GST-tagged recombinant
proteins were pre-clarified at 100,0006g, and their concentrations
were determined by the Bradford assay (Bio-Rad) using bovine
serum albumin as a standard. Purified His-SipC, His-SipC-C and
His-SipC-N and its derivatives were immobilized on Ni-nitrilo-
triacetic acid beads (NOVAGEN, Gibbstown, NJ) for 1 hr at 4uC
and washed three times with cold PBS. Equal concentrations of
GST or GST-SicA were added to the immobilized His fusion
proteins and incubated for 2 hrs at 4uC under gentle rotation. The
mixtures were subsequently washed four times in PBS containing
1% NP-40, and then eluted from the beads by addition of
Laemmli loading buffer, boiled and resolved by SDS-PAGE along
with pre-incubation samples (inputs) of the reactions. Samples
were further analyzed by Western blotting using monoclonal anti-
His antibody (Invitrogen) and rabbit polyclonal anti-GST
antibody. The anti-M45 McAb used was a gift from Dr. Patrick
Hearing at SUNY Stony Brook, New York.
Chymotrypsin Digestion
Secreted SipC was prepared from bacterial cultures grown as
described above. Limited proteolysis was carried out in chymo-
trypsin at 25uC. Samples were taken at different time intervals and
digestion products were separated by SDS-PAGE and subjected to
western blotting using polyclonal anti-SipC antibody.
Cell Fractionation Assays
Salmonella strains were grown as described above. Cytosolic and
plasma-membrane associated proteins in Salmonella-infected host
cells were assessed as described previously [13,33]. Briefly, HeLa
cells were infected with Salmonella at a multiplicity of 100 for
60 min in Hanks balanced salt solution (HBSS). Infected cells were
washed with PBS and incubated in Dulbecco’s modified Eagle
medium containing 100 mg/ml of gentamicin for 30 min at 37uC
to kill extracellular bacteria. Infected cells were treated with
Proteinase K (50 mgml21) for 15 min at 37uC to minimize
extracellular-associated secreted proteins and collected by low-
speed centrifugation. To extract cytosolic proteins, cells were lysed
in 50 mM Tris-HCl, pH 7.5, 1 mM PMSF, and protein inhibitor
cocktail (Sigma) containing 0.2% saponin. Lysates were clarified at
20,0006 g at 4uC for 60 min; supernatant fractions containing
cytosolic proteins were collected for SDS-PAGE and western blot
analysis. The saponin insoluble fractions containing membrane
associated proteins were lysed in membrane buffer (10 mM Tris-
HCl, pH 7.4, 5 mM MgCl2, 1 mM PMSF, and protein inhibitor
cocktail (Sigma) containing 0.15 M NaCl 1% Triton X-100 for
60 min at 4uC. Membrane associated proteins were collected by
centrifugation and subjected to SDS-PAGE and western blotting.
The above detergent based fractionation assays to extract cytosolic
and membrane associated proteins were routinely verified using
the mechanical fractionation assay as previously described [34].
When indicated, transfected cells were lysed 48 hrs post-transfec-
tion as described above to extract cytosolic and then membrane
associated proteins.
Hemolysis Assay
The contact mediated hemolysis of sheep erythrocytes was
performed as previously described [15]. Briefly, Salmonella strains
were grown overnight in BHI medium at 37uC under static
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conditions. The bacteria were sub-cultured (1:50) into fresh BHI
medium and grown to mid-log phase. The bacteria were collected
by centrifugation and resuspended in BHI. Sheep red blood cells
were washed three times with PBS and resuspended in BHI (50%
v/v). Equal volumes of red blood cell suspension and bacteria
(16109 cfuml21) were added to 24-well micro titer plates,
centrifuged at 2,0006 g for 10 min at 20uC to facilitate close
contact between the bacteria and red blood cells. The red blood
cells and bacterial suspensions were then incubated at 37uC for
4 hrs, resuspended in 100 ml PBS, and centrifuged at 2,0006 g for
10 min. The supernatant fractions were transferred to a clean
micro titer plate and the absorbance of released hemoglobin
measured at 595 nm. For osmoprotection assays, hemolysis assays
in the presence or absence of 30 mM carbohydrates raffinose,
PEG1000, PEG1500, PEG2000, and PEG3000 were performed in
a similar manner. The examination of SipC associated with RBC
after hemolysis was performed as previously described [10] by
floatation in a sucrose density gradient. Proteins associated with
RBC membranes were subjected to SDS-PAGE and western
blotting using anti-SipC and anti-SipB antibodies.
Supporting Information
Figure S1 The stability of the wild SipC protein and its
derivatives assessed by limited proteolysis. Salmonella
culture supernatants (secreted proteins) grown under SPI-1
conditions were incubated with chymotrypsin at 25uC. Aliquots
were taken from the reaction mixture at the indicated time
intervals and the degradation was monitored by SDS-PAGE and
Western blotting analysis with polyclonal anti-SipC antibody.
(PDF)
Figure S2 The wild-type SipC and its mutant derivatives
are targeted to the membrane when expressed in HeLa
cells. HeLa cells were transfected with plasmids expressing wild-
type SipC and its mutant derivatives. 48 hrs post transfection, cells
were fractionated and subjected to SDS-PAGE and Western
blotting analysis with antibodies against SipC, caveoli-1 (mem-
brane), and Hsp90 (cytoplasmic).
(PDF)
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